Pharma Reviews: India puts 42 non-scheduled cancer drugs under price control

The National Pharmaceutical Pricing Authority (NPPA) approved the formula which restricts the trade margin of the selling price by up to 30%.
Read more: India puts 42 non-scheduled cancer drugs under price control